FDG PET Scan Based Response Assesment in Non-Small Cell Lung Cancer Treated With Chemoradiotherapy And Neoadjuvant Chemotherapy

被引：0
|
作者：
Ahmad, A. [1 ]
Majumdar, S. K. D. [1 ]
Parida, D. K. [1 ]
Barik, S. K. [1 ]
Das, D. K. [1 ]
Bagul, D. Y. [2 ]
Shaikh, L. [2 ]
Amin, N. [3 ]
机构：
[1] All India Inst Med Sci AIIMS Bhubaneswar, Bhubaneswar, India
[2] Index Med Coll Indore, Indore, India
[3] Bharti Vidyapeeth Med Coll, Pune, Maharashtra, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non Small Cell Lung Cancer; Chemoradiotherapy; FDG PET scan;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-07
引用
收藏
页码：S571 / S571
页数：1
相关论文
共 50 条
  • [1] FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
    Ryu, JS
    Choi, NC
    Fischman, AJ
    Lynch, TJ
    Mathisen, DJ
    LUNG CANCER, 2002, 35 (02) : 179 - 187
  • [2] LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY
    Maliarchuk, Katerina
    Ganul, Andrey
    Borisyuk, Bogdan
    Bororov, Leonid
    Shevchenko, Anatoly
    Sovenko, Vladimir
    Kutsenko, Lubov
    HEALTH PROBLEMS OF CIVILIZATION, 2022, 16 (04) : 302 - 311
  • [3] Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects
    Edelman, MJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) : 843 - 852
  • [4] 18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
    Usmanij, Edwin A.
    de Geus-Oei, Lioe-Fee
    Troost, Esther G. C.
    Peters-Bax, Liesbeth
    van der Heijden, Erik H. F. M.
    Kaanders, Johannes H. A. M.
    Oyen, Wim J. G.
    Schuurbiers, Olga C. J.
    Bussink, Johan
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (09) : 1528 - 1534
  • [5] Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer
    Yuka Yamamoto
    Yoshihiro Nishiyama
    Toshihide Monden
    Yasuhiro Sasakawa
    Motoomi Ohkawa
    Masashi Gotoh
    Kotaro Kameyama
    Reiji Haba
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 140 - 147
  • [6] Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Kim, Suzy
    Oh, So Won
    Kim, Jin Soo
    Kim, Ki Hwan
    Kim, Yu Kyeong
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (04): : 231 - 237
  • [7] Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer
    Yamamoto, Y
    Nishiyama, Y
    Monden, T
    Sasakawa, Y
    Ohkawa, M
    Gotoh, M
    Kameyama, K
    Haba, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 140 - 147
  • [8] Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer
    de Geus-Oei, Lioe-Fee
    van der Heijden, Henricus F. M.
    Visser, Eric P.
    Hermsen, Rick
    van Hoorn, Bas A.
    Timmer-Bonte, Johanna N. H.
    Willemsen, Antoon T.
    Pruim, Jan
    Corstens, Frans H. M.
    Krabbe, Paul F. M.
    Oyen, Wim J. G.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) : 1592 - 1598
  • [9] Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
    Eschmann, S. M.
    Friedel, G.
    Paulsen, F.
    Reimold, M.
    Hehr, T.
    Budach, W.
    Dittmann, H.
    Langen, H. -J.
    Bares, R.
    LUNG CANCER, 2007, 55 (02) : 165 - 171
  • [10] Neoadjuvant chemotherapy for early stage non-small cell lung cancer
    Beitler, AL
    Urschel, JD
    Takita, H
    MEDICAL SCIENCE RESEARCH, 1998, 26 (12): : 853 - 854
12345